These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2881902)

  • 41. Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; "EVE").
    Boja JW; Schechter MD
    Pharmacol Biochem Behav; 1987 Oct; 28(2):153-6. PubMed ID: 2891144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Some observations on MDMA experiences induced through posthypnotic suggestion.
    Hastings A
    J Psychoactive Drugs; 1994; 26(1):77-83. PubMed ID: 7913132
    [No Abstract]   [Full Text] [Related]  

  • 43. Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex.
    Pierce PA; Peroutka SJ
    Neurosci Lett; 1988 Dec; 95(1-3):208-12. PubMed ID: 2906416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.
    Nichols DE
    J Psychoactive Drugs; 1986; 18(4):305-13. PubMed ID: 2880944
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 46. Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
    Lowy MT; Nash JF; Meltzer HY
    Eur J Pharmacol; 1989 Apr; 163(1):157-61. PubMed ID: 2472965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.
    Spanos LJ; Yamamoto BK
    Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The scheduling of MDMA: a pharmacist's perspective.
    Riedlinger JE
    J Psychoactive Drugs; 1985; 17(3):167-71. PubMed ID: 2865343
    [No Abstract]   [Full Text] [Related]  

  • 49. MDMA. Nonmedical use and intoxication.
    Siegel RK
    J Psychoactive Drugs; 1986; 18(4):349-54. PubMed ID: 2880950
    [No Abstract]   [Full Text] [Related]  

  • 50. Legal limbo for ecstasy.
    Barnes DM
    Science; 1988 Feb; 239(4842):865. PubMed ID: 2893453
    [No Abstract]   [Full Text] [Related]  

  • 51. Orally administered MDMA causes a long-term depletion of serotonin in rat brain.
    Finnegan KT; Ricaurte GA; Ritchie LD; Irwin I; Peroutka SJ; Langston JW
    Brain Res; 1988 Apr; 447(1):141-4. PubMed ID: 2898273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R; Nichols DE
    Psychopharmacology (Berl); 1988; 95(1):71-6. PubMed ID: 2898791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat.
    Crisp T; Stafinsky JL; Boja JW; Schechter MD
    Pharmacol Biochem Behav; 1989 Nov; 34(3):497-501. PubMed ID: 2576139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
    Gazzara RA; Takeda H; Cho AK; Howard SG
    Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered states: the clinical effects of Ecstasy.
    Cole JC; Sumnall HR
    Pharmacol Ther; 2003 Apr; 98(1):35-58. PubMed ID: 12667887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs.
    Glennon RA; Yousif M; Patrick G
    Pharmacol Biochem Behav; 1988 Mar; 29(3):443-9. PubMed ID: 2896360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
    Kikura R; Nakahara Y; Mieczkowski T; Tagliaro F
    Forensic Sci Int; 1997 Jan; 84(1-3):165-77. PubMed ID: 9042722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.
    Yamamoto BK; Spanos LJ
    Eur J Pharmacol; 1988 Mar; 148(2):195-203. PubMed ID: 2897922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys.
    Thompson DM; Winsauer PJ; Mastropaolo J
    Pharmacol Biochem Behav; 1987 Feb; 26(2):401-5. PubMed ID: 2883665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ; Robinson SE; Rosecrans JA
    Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.